MONTREAL, Aug. 29 /CNW Telbec/ - (TSX-V: BUG) - Biophage Pharma Inc. (TSX.V: BUG) announced today that it is developing an innovative integrated approach for the management of bacterial contamination in hospitals. The tandem development of its PDS(R) Biosensor will identify Antibiotic Resistant bacteria and the novel approaches to phage therapy will then be applied to contain these infections.
